Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.32 0.1099 +52.31%
CYTK $12.99 1.0699 +8.98%
ARRY $4.09 0.2900 +7.63%
IMNP $4.10 0.1400 +3.54%
VRML $3.00 0.1000 +3.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

AGIO $43.58 -2.7600 -5.96%
MEIP $8.58 -0.4900 -5.40%
OMED $25.96 -1.2200 -4.49%
CVM $1.22 -0.0500 -3.94%
MDVN $57.72 -2.3200 -3.86%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

U.S. Official Responsible for Reforming Medicare Is Leaving Post

(Reuters) Apr 22, 2014 - The Obama administration on Tuesday announced the departure of the top health official responsible for reforming Medicare under President Barack Obama's healthcare reform law.
read article 

New Migraine Treatments Show Promise

(CNN) Apr 22, 2014 - There are few treatments available for the millions of people who suffer from migraines. New early-stage research offers new hope.
read article 

Gilead Revenue Soars on Hepatitis C Drug

(New York Times) Apr 22, 2014 - Record sales of a new hepatitis C drug pushed the first-quarter earnings of Gilead Sciences far beyond expectations, the company reported on Tuesday, but could also heighten concerns about the high cost of the drug, known as Sovaldi, and the ability of the health care system to pay for it.
read article 

FDA Advisers Vote Against Approving New Opioid Painkiller

(NPR/Shots blog) Apr 22, 2014 - A key government panel Tuesday voted unanimously against approval of a powerful opioid prescription painkiller intended to provide faster relief with fewer side effects.
read article 

FDA Plan Would Speed Up Medical Device Approvals

(Washington Post/Associated Press) Apr 22, 2014 - The Food and Drug Administration unveiled a proposal Tuesday designed to speed up development and approval of medical devices that treat life-threatening diseases and debilitating conditions.
read article (free registration required) 

Drugmakers in Deal Frenzy Seek to Be First, Best or Gone

(Bloomberg) Apr 23, 2014 - Do a few things, and do them well. That’s the strategy the drug industry is following in a wave of deals where small companies are getting bigger and the big ones are getting smaller.
read article 

Finalists Announced for 2014 Extraordinary Healer Award for Oncology Nursing

(The US Oncology Network) Apr 23, 2014 - CURE magazine, the most widely distributed magazine in the nation for people with cancer, has announced the three finalists for the 2014 Extraordinary Healer Award for Oncology Nursing.
read corporate press release 

UMass Memorial Medical Center/Health Alliance Announces Cuts to Staff & Services at Burbank Hospital Urgent Care Unit and Cancer Center

(Massachusetts Nurses Association) Apr 22, 2014 - In the wake of last week's announcement of major service cuts and layoffs to their Worcester-based facilities, UMass Memorial Medical Center has also announced significant cuts to services and staff.
read press release 

Local Providers Join Forces to Enhance Access to Integrated Cancer Care

(21st Century Oncology) Apr 22, 2014 - 21st Century Oncology, the nation’s leading provider of cancer care services across multiple modalities, today announces plans to work with Lower Keys Medical Center and Rural Health Network of Monroe County Florida, Inc. to provide integrated medical oncology and hematology services in our community.
read corporate press release 

MolecularMatch Uses Health IT Software for Better Clinical Trials

(Xconomy Texas) Apr 22, 2014 - Connecting cancer patients to clinical trials that could help them is an expensive and inefficient process. Houston’s MolecularMatch says they have a better way, an approach that combines Google search with
read article 

Tolero Pharmaceuticals Receives FDA Orphan Drug Designation for Alvocidib for the Treatment of Acute Myeloid Leukemia

(Yahoo! Finance) Apr 23, 2014 - Tolero Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
read article 

OncoGenex Announces Fast Track Designation Granted for Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Phase 3 AFFINITY Trial of Men with Metastatic Castrate-Resistant Prostate Cancer

(Yahoo! Finance) Apr 23, 2014 - OncoGenex Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of custirsen when administered in combination with cabazitaxel/prednisone for the treatment of men with metastatic castrate-resistant prostate cancer (CRPC) following prior treatment with a docetaxel-containing regimen.
read article 

Spectrum Pharma to Seek Cancer Drug Approval in 3rd Qtr

(Reuters) Apr 23, 2014 - Spectrum Pharmaceuticals Inc said it expects to seek U.S. marketing approval for its blood cancer drug in the third quarter, after the treatment was shown to be safe and effective in a key mid-stage trial.
read article 

Novartis Cancer Move Adds Spice to Rivalry with Roche

(Bloomberg) Apr 23, 2014 - Sitting just two miles apart on opposite banks of the Rhine river in Basel, Switzerland, Novartis AG and Roche Holding AG have long had a complex crosstown rivalry.
read article 

Anatomy of the Cost of a New Drug

(BBC News) Apr 23, 2014 - The cost of drugs is in the headlines following the decision by NHS watchdog NICE that a new cancer treatment should not be funded.
read article 

CMS to Weigh Medicare Coverage of CT Scans for Smokers

(Modern Healthcare) Apr 21, 2014 - Dr. Barry Kramer, director of the National Cancer Institute's Division of Cancer Prevention, once had doubts that using low-dose CT scans to detect early lung cancer is a good idea.
read article (free registration required) 

June 25, 2014: Oncologic Drugs Advisory Committee Meeting Announcement

( Apr 21, 2014 - Agenda: The committee will discuss new drug application (NDA) 206162, olaparib capsules, application submitted by AstraZeneca Pharmaceuticals LP.
read article  

2014 ASCO Annual Meeting Press Program to Highlight Major Advances in Cancer Research

(ASCO) Apr 23, 2014 - The American Society of Clinical Oncology (ASCO) today announced the studies to be featured in the 2014 ASCO Annual Meeting press program.
read press release 

Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy) in Advanced Melanoma

(MarketWatch) Apr 23, 2014 - Peregrine Pharmaceuticals, Inc. today announced the opening of an investigator-sponsored trial (IST) of its investigational immunotherapy bavituximab in combination with Bristol-Myers Squibb's ipilimumab (Yervoy), for the treatment of advanced melanoma.
read article 

Suicides Among Cancer Patients 20 Times That of General Population

(The Japan Times) Apr 23, 2014 - Cancer patients are 20 times more likely to commit suicide within the first year of their diagnosis than members of the general population, according to new findings.
read article 

Parkinson's Drug Could Help Prevent Breast Cancer In High-Risk Women

(Huffington Post/LiveScience) Apr 23, 2014 - Women with mutations in the BRCA1 gene are at high risk for breast and ovarian cancer, and there are currently no drugs proven to reduce their cancer risk.
read article 

People With Kidney Disease Show Higher Cancer Risk in Study

(U.S. News & World Report/HealthDay News) Apr 23, 2104 - Older adults with moderate kidney dysfunction may face a higher risk of developing cancer than those with healthy kidneys, a large study suggests.
read article 

Sunitinib-Related Fatigue Occurs Early Then Tails Off During RCC Treatment

( Apr 22, 2014 - Patients beginning sunitinib treatment for advanced renal cell carcinoma (RCC) should be warned that fatigue is likely to occur early, but that it is unlikely to worsen over the course of treatment, suggest US researchers in Cancer.
read article 

Radical Surgery for Mesothelioma: Still Controversial

(Medscape Medical News) Apr 22, 2014 - The role of radical surgery in the treatment of malignant pleural mesothelioma has been the subject of much heated debate in the last few years, as thoracic surgeons argue over the details of a small but landmark clinical trial that failed to show any benefit from a highly complex operation, extrapleural pneumonectomy (EPP).
read article (free registration required) 

How Big Pharma Holds Back in the War on Cancer

(The Daily Beast) Apr 23, 2014 - Big Pharma’s focus on blockbuster cancer drugs squeezes out cheaper treatments. The result, one researcher says: ‘If we’re winning the war on cancer, we’re not winning that fast.’
read article